E
B. Van Phuc et al.
Letter
Synlett
(12) (a) Moon, J. S.; Ahn, D. H.; Kim, S. W.; Lee, S. Y.; Lee, J. Y.; Kwon,
J. H. RSC Adv. 2018, 8, 17025. (b) Im, Y.; Lee, J. Y. Chem. Commun.
2013, 49, 5948. (c) Junyou, P.; Hong, H. WO2018095396A1,
2017.
(13) Peng, H.; Chen, X.; Chen, Y.; He, Q.; Xie, Y.; Yang, C. Tetrahedron
2011, 67, 5725.
(14) Movassaghi, M.; Hill, M. D. Org. Lett. 2008, 10, 3485.
(15) Audia, J. E.; Droste, J. J.; Nissen, J. S.; Murdoch, G. L.; Evrard, D. A.
J. Org. Chem. 1996, 61, 7937.
(16) Laha, J. K.; Barolo, S. M.; Rossi, R. A.; Cuny, G. D. J. Org. Chem.
2011, 76, 6421.
(17) (a) Shu, C.; Wang, Y.-H.; Zhou, B.; Li, X.-L.; Ping, Y.-F.; Lu, X.; Ye,
L.-W. J. Am. Chem. Soc. 2015, 137, 9567. (b) Nissen, F.; Richard,
V.; Alayrac, C.; Witulski, B. Chem. Commun. 2011, 47, 6656.
(c) Li, L.; Chen, X.-M.; Wang, Z.-S.; Zhou, B.; Liu, X.; Lu, X.; Ye, L.-
W. ACS Catal. 2017, 7, 4004. (d) Iwaki, T.; Yasuhara, A.;
Sakamoto, T. J. Chem. Soc., Perkin Trans. 1 1999, 1505. (e) Zhang,
H.; Larock, R. C. J. Org. Chem. 2002, 67, 9318. (f) Zhang, H.;
Larock, R. C. Org. Lett. 2001, 3, 3083. (g) Too, P. C.; Chua, S. H.;
Wong, S. H.; Chiba, S. J. Org. Chem. 2011, 76, 6159. (h) Ding, S.;
Shi, Z.; Jiao, N. Org. Lett. 2010, 12, 1540. (i) Namjoshi, O. A.;
Gryboski, A.; Fonseca, G. O.; Van Linn, M. L.; Wang, Z.-j.;
Deschamps, J. R.; Cook, J. M. J. Org. Chem. 2011, 76, 4721.
(j) Tang, S.; Wang, J.; Xiong, Z.; Xie, Z.; Li, D.; Huang, J.; Zhu, Q.
Org. Lett. 2017, 19, 5577. (k) Alves Esteves, C. H.; Smith, P. D.;
Donohoe, T. J. J. Org. Chem. 2017, 82, 4435. (l) Kamlah, A.; Lirk,
F.; Bracher, F. Tetrahedron 2016, 72, 837. (m) Hung, T. Q.; Hieu,
D. T.; Van Tinh, D.; Do, H. N.; Nguyen Tien, T. A.; Van Do, D.; Son,
L. T.; Tran, N. H.; Van Tuyen, N.; Tan, V. M.; Ehlers, P.; Dang, T. T.;
Langer, P. Tetrahedron 2019, 75, 130569. (n) Yang, C.-C.; Tai, H.-
column chromatography (silica gel, hexane/ethyl acetate = 20:1)
to yield 3-bromo-2-(2-bromophenyl)pyridine (1a)17s (2.20 g,
85%) as a colorless oil.
(21) General Procedure for the Synthesis of 5H-Pyrido[3,2-
b]indoles 3a–o
3-Bromo-2-(2-bromophenyl)pyridine (1a, 100 mg, 0.32 mmol),
4-fluoroaniline (116 mg, 0.958 mmol), copper(I) iodide (12 mg,
0.064 mmol, Aldrich, 99%), L-proline (11 mg, 0.096 mmol), and
K2CO3 (132 mg, 0.958 mmol) were dissolved in DMSO (1.5 mL)
and heated at 120 °C for 24 h. After cooling, the reaction
mixture was poured into water (50 mL) and extracted with
ethyl acetate (3 × 50 mL). The organic layer was dried over
MgSO4, filtered, and the solvent was evaporated in vacuo. The
residue was purified by column chromatography (silica gel, hex-
ane/ethyl acetate = 5:1) to yield 5-(4-methylbenzyl)-5H-pyr-
ido[3,2-b]indole (3b, 85 mg, 95%) as a white solid. 1H NMR (500
MHz, CDCl3): = 8.57 (s, 1 H), 8.46 (s, 1 H), 7.65 (s, 1 H), 7.56–
7.50 (m, 1 H), 7.42 (d, J = 8.2 Hz, 1 H), 7.35 (d, J = 6.8 Hz, 2 H),
7.07 (d, J = 7.9 Hz, 2 H), 7.01 (d, J = 7.9 Hz, 2 H), 5.47 (s, 2 H), 2.29
(s, 3 H). 13C NMR (126 MHz, CDCl3): = 141.4, 137.5, 133.5,
129.6, 127.9, 126.4, 120.2, 109.3, 21.1. HRMS (ESI): m/z calcd for
C19H16N2 [M + 1]+: 273.1386; found: 273.1401.
(22) Preparation of 3-Bromo-4-(2-bromophenyl)pyridine (1b)
3,4-Dibromopyridine (2.00 g, 8.44 mmol), 2-bromophenylbo-
ronic acid (1.70 g, 8.44 mmol), and Pd(PPh3)4 (488 mg, 0.422
mmol) were added to a 250 mL Schlenk flask. The mixture was
backfilled several times with argon. To the mixture were added
K2CO3 (1 M, 25 mL), 5 drops of aqueous KOH (10%), and 35 mL of
THF, then backfilled several times with argon. The reaction was
heated at 70 °C for 18 h. The solvent was evaporated in vacuo.
The residue was extracted with ethyl acetate and water. The
organic layer was dried over MgSO4, filtered, and the solvent
was evaporated in vacuo. The residue was purified by column
chromatography (silica gel, hexane/ethyl acetate = 20:1) to yield
3-bromo-4-(2-bromophenyl)pyridine (1b)17m (2.30 g, 80%) as a
colorless syrup.
M.; Sun, P.-J. J. Chem. Soc., Perkin Trans.
1 1997, 2843.
(o) Papamicaël, C.; Quéguiner, G.; Bourguignon, J.; Dupas, G.
Tetrahedron 2001, 57, 5385. (p) Mazu, T. K.; Etukala, J. R.; Jacob,
M. R.; Khan, S. I.; Walker, L. A.; Ablordeppey, S. Y. Eur. J. Med.
Chem. 2011, 46, 2378. (q) Detert, H.; Letessier, J. Synthesis 2011,
290. (r) Cao, J.; Xu, Y.; Kong, Y.; Cui, Y.; Hu, Z.; Wang, G.; Deng,
Y.; Lai, G. Org. Lett. 2012, 14, 38. (s) Hung, T. Q.; Dang, T. T.;
Janke, J.; Villinger, A.; Langer, P. Org. Biomol. Chem. 2015, 13,
1375.
(23) General Procedure for the Synthesis of 9H-pyrido[3,4-
b]indoles 4a–h
3-Bromo-2-(2-bromophenyl)pyridine (1a, 100 mg, 0.32 mmol),
4-fluoroaniline (116 mg, 0.958 mmol), copper(I) iodide (15.4
mg, 0.08 mmol), L-proline (11 mg, 0.096 mmol), and K2CO3 (132
mg, 0.958 mmol) were dissolved in DMSO (1.5 mL) and heated
at 160 °C for 24 h. After cooling, the reaction mixture was
poured into water (50 mL) and extracted with ethyl acetate (3 ×
50 mL). The organic layer was dried over MgSO4, filtered, and
the solvent was evaporated in vacuo. The residue was purified
by column chromatography (silica gel, hexane/ethyl acetate =
5:1) to yield 9-phenethyl-9H-pyrido[3,4-b]indole (4e, 61 mg,
(18) Do, H. N.; Quan, N. M.; Van Phuc, B.; Van Tinh, D.; Tien, N. Q.;
Nga, T. T. T.; Nguyen, V. T.; Hung, T. Q.; Dang, T. T.; Langer, P.
Synlett 2021, 32, 611.
(19) (a) Ma, D.; Cai, Q. Acc. Chem. Res. 2008, 41, 1450. (b) Zhang, H.;
Cai, Q.; Ma, D. J. Org. Chem. 2005, 70, 5164.
(20) Preparation of 3-Bromo-2-(2-bromophenyl)pyridine (1a)
2,3-Dibromopyridine (2.00 g, 8.44 mmol), 2-bromophenyl
boronic acid (1.70 g, 8.44 mmol), and Pd(PPh3)4 (488 mg, 0.422
mmol) were added to a 250 mL Schlenk flask. The mixture was
backfilled several times with argon. To the mixture were added
K2CO3 (1 M, 25 mL), 5 drops of aqueous KOH (10%) and 35 mL of
THF, then backfilled several times with argon. The reaction was
heated at 70 °C for 18 h. The solvent was evaporated in vacuo.
The residue was extracted with ethyl acetate and water. The
organic layer was dried over MgSO4, filtered, and the solvent
was evaporated in vacuo. The yellow residue was purified by
1
70%) as a white solid. H NMR (500 MHz, CDCl3): = 8.72 (s, 1
H), 8.43 (d, J = 4.9 Hz, 1 H), 8.14 (dt, J = 7.9, 1.0 Hz, 1 H), 7.95 (d,
J = 5.2 Hz, 1 H), 7.56 (ddd, J = 8.4, 7.1, 1.2 Hz, 1 H), 7.39–7.33 (m,
1 H), 7.32–7.23 (m, 2 H), 7.25–7.20 (m, 1 H), 7.23–7.17 (m, 2 H),
7.17 (ddt, J = 7.7, 5.7, 1.6 Hz, 1 H), 7.11–7.05 (m, 2 H), 4.59 (t, J =
7.4 Hz, 2 H), 3.15 (t, J = 7.4 Hz, 2 H). 13C NMR (126 MHz, CDCl3):
= 141.1, 138.5, 138.2, 131.7, 128.8, 128.7, 128.7, 128.6, 128.5,
126.9, 126.4, 122.0, 121.1, 119.8, 109.4, 45.3, 35.5. HRMS (ESI):
m/z calcd for C19H16N2 [M + 1]+: 273.1386; found: 273.1400.
© 2021. Thieme. All rights reserved. Synlett 2021, 32, A–E